William Wells
2009
In 2009, William Wells earned a total compensation of $3.7M as Chief Executive Officer at Valeant Pharmaceuticals International, a 15% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,289,484 |
|---|---|
| Option Awards | $102,421 |
| Salary | $860,085 |
| Stock Awards | $1,329,531 |
| Other | $107,686 |
| Total | $3,689,207 |
Wells received $1.3M in stock awards, accounting for 36% of the total pay in 2009.
Wells also received $1.3M in non-equity incentive plan, $102.4K in option awards, $860.1K in salary and $107.7K in other compensation.
Rankings
In 2009, William Wells' compensation ranked 1,165th out of 9,885 executives tracked by ExecPay. In other words, Wells earned more than 88.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,165 out of 9,885 | 88th |
Division Manufacturing | 410 out of 3,690 | 89th |
Major group Chemicals And Allied Products | 88 out of 871 | 90th |
Industry group Drugs | 59 out of 643 | 91st |
Industry Pharmaceutical Preparations | 50 out of 446 | 89th |
Source: SEC filing on April 14, 2011.
Wells' colleagues
We found six more compensation records of executives who worked with William Wells at Valeant Pharmaceuticals International in 2009.
2009
William Wells
Valeant Pharmaceuticals International
Chief Executive Officer
2009
Gilbert Godin
Valeant Pharmaceuticals International
Chief Operating Officer
2009
Christian Fibiger
Valeant Pharmaceuticals International
Chief Scientific Officer
2009
Gregory Gubitz
Valeant Pharmaceuticals International
General Counsel
2009
Margaret Mulligan
Valeant Pharmaceuticals International
Chief Financial Officer
2009
Mark Durham
Valeant Pharmaceuticals International